|
1.
|
L YangIncidence and mortality of gastric
cancer in ChinaWorld J Gastroenterol1217202006
|
|
2.
|
DM ParkinF BrayJ FerlayP PisaniGlobal
cancer statistics, 2002CA Cancer J
Clin5574108200510.3322/canjclin.55.2.74
|
|
3.
|
I ChauAR NormanD CunninghamJS WatersJ
OatesPJ RossMultivariate prognostic factor analysis in locally
advanced and metastatic esophago-gastric cancer – pooled analysis
from three multicenter, randomized, controlled trials using
individual patient dataJ Clin Oncol2223952403200415197201
|
|
4.
|
P HohenbergerS GretschelGastric
cancerLancet362305315200310.1016/S0140-6736(03)13975-X
|
|
5.
|
S CurranGI MurrayMatrix metalloproteinases
in tumour invasion and metastasisJ
Pathol189300308199910.1002/(SICI)1096-9896(199911)189:3%3C300::AID-PATH456%3E3.0.CO;2-C10547590
|
|
6.
|
ND RawlingsFR MortonAJ BarrettMEROPS: the
peptidase databaseNucleic Acids
Res34D270D272200610.1093/nar/gkj08916381862
|
|
7.
|
C QuemenerEE GabisonB NaimiExtracellular
matrix metalloproteinase inducer up-regulates the urokinase-type
plasminogen activator system promoting tumor cell invasionCancer
Res67915200710.1158/0008-5472.CAN-06-244817210677
|
|
8.
|
CV ObiezuEP DiamandisHuman tissue
kallikrein gene family: applications in cancerCancer
Lett224122200510.1016/j.canlet.2004.09.02415911097
|
|
9.
|
JT KimEY SongKS ChungUp-regulation and
clinical significance of serine protease kallikrein 6 in colon
cancerCancer117112201121656738
|
|
10.
|
JC WhisstockSP BottomleyPI BirdRN PikeP
CoughlinSerpins 2005 – fun between the beta-sheets. Meeting report
based upon presentations made at the 4th International Symposium on
Serpin Structure, Function and Biology (Cairns, Australia)FEBS
J272486848732005
|
|
11.
|
JA IrvingRN PikeAM LeskJC
WhisstockPhylogeny of the serpin superfamily: implications of
patterns of amino acid conservation for structure and
functionGenome Res1018451864200010.1101/gr.GR-1478R11116082
|
|
12.
|
JA IrvingSS ShushanovRN PikeInhibitory
activity of a heterochromatin-associated serpin (MENT) against
papain-like cysteine proteinases affects chromatin structure and
blocks cell proliferationJ Biol
Chem2771319213201200210.1074/jbc.M108460200
|
|
13.
|
C SchickD BrommeAJ BartuskiY UemuraNM
SchechterGA SilvermanThe reactive site loop of the serpin SCCA1 is
essential for cysteine proteinase inhibitionProc Natl Acad Sci
USA951346513470199810.1073/pnas.95.23.134659811823
|
|
14.
|
Y SuminamiS NagashimaA MurakamiSuppression
of a squamous cell carcinoma (SCC)-related serpin, SCC antigen,
inhibits tumor growth with increased intratumor infiltration of
natural killer cellsCancer Res6117761780200111280721
|
|
15.
|
Y SuminamiS NagashimaNL VujanovicK
HirabayashiH KatoTL WhitesideInhibition of apoptosis in human
tumour cells by the tumour-associated serpin, SCC antigen-1Br J
Cancer82981989200010.1054/bjoc.1999.102810732775
|
|
16.
|
Z ZouA AnisowiczMJ HendrixMaspin, a serpin
with tumor-suppressing activity in human mammary epithelial
cellsScience263526529199410.1126/science.82909628290962
|
|
17.
|
TD ShellenbergerA MazumdarY
HendersonHeadpin: a serpin with endogenous and exogenous
suppression of angiogenesisCancer
Res651150111509200510.1158/0008-5472.CAN-05-226216357159
|
|
18.
|
GJ OllinsN NikitakisK NorrisC HerbertH
SiavashJJ SaukThe production of the endostatin precursor collagen
XVIII in head and neck carcinomas is modulated by
CBP2/Hsp47Anticancer Res2219771982200212174873
|
|
19.
|
G XiaoYE LiuR GentzSuppression of breast
cancer growth and metastasis by a serpin myoepithelium-derived
serine proteinase inhibitor expressed in the mammary myoepithelial
cellsProc Natl Acad Sci USA9637003705199910.1073/pnas.96.7.3700
|
|
20.
|
MJ DuffyC DugganThe urokinase plasminogen
activator system: a rich source of tumour markers for the
individualised management of patients with cancerClin
Biochem37541548200415234235
|
|
21.
|
M ShiibaH NomuraK ShinozukaDown-regulated
expression of SERPIN genes located on chromosome 18q21 in oral
squamous cell carcinomasOncol
Rep24241249201010.3892/or_0000085220514468
|
|
22.
|
GA SilvermanPI BirdRW CarrellThe serpins
are an expanding superfamily of structurally similar but
functionally diverse proteins. Evolution, mechanism of inhibition,
novel functions, and a revised nomenclatureJ Biol
Chem2763329333296200110.1074/jbc.R100016200
|
|
23.
|
GM YousefEP DiamandisTissue kallikreins:
new players in normal and abnormal cell growth?Thromb
Haemost90716200312876620
|
|
24.
|
J HuangHH ShengT ShenCorrelation between
genomic DNA copy number alterations and transcriptional expression
in hepatitis B virus-associated hepatocellular carcinomaFEBS
Lett58035713581200610.1016/j.febslet.2006.05.032
|
|
25.
|
XR XuJ HuangZG XuInsight into
hepatocellular carcinogenesis at transcriptome level by comparing
gene expression profiles of hepatocellular carcinoma with those of
corresponding noncancerous liverProc Natl Acad Sci
USA981508915094200110.1073/pnas.241522398
|
|
26.
|
YH YangS DudoitP LuuNormalization for cDNA
microarray data: a robust composite method addressing single and
multiple slide systematic variationNucleic Acids
Res30e15200210.1093/nar/30.4.e1511842121
|
|
27.
|
KF LeiYF WangXQ ZhuIdentification of MSRA
gene on chromosome 8p as a candidate metastasis suppressor for
human hepatitis B virus-positive hepatocellular carcinomaBMC
Cancer7172200710.1186/1471-2407-7-17217784942
|
|
28.
|
KJ LivakTD SchmittgenAnalysis of relative
gene expression data using real-time quantitative PCR and the
2(−Delta Delta C(T)) MethodMethods254024082001
|
|
29.
|
Y QuJF LiQ CaiOver-expression of FRZB in
gastric cancer cells suppresses proliferation and induces
differentiationJ Cancer Res Clin
Oncol134353364200810.1007/s00432-007-0291-017680269
|
|
30.
|
JM HarveyGM ClarkCK OsborneDC
AllredEstrogen receptor status by immunohistochemistry is superior
to the ligand-binding assay for predicting response to adjuvant
endocrine therapy in breast cancerJ Clin Oncol17147414811999
|
|
31.
|
S MichielsS KoscielnyC HillInterpretation
of microarray data in cancerBr J
Cancer9611551158200710.1038/sj.bjc.660367317342085
|
|
32.
|
QH YeLX QinM ForguesPredicting hepatitis B
virus-positive metastatic hepatocellular carcinomas using gene
expression profiling and supervised machine learningNat
Med9416423200310.1038/nm843
|
|
33.
|
EJ YeohME RossSA ShurtleffClassification,
subtype discovery, and prediction of outcome in pediatric acute
lymphoblastic leukemia by gene expression profilingCancer
Cell1133143200210.1016/S1535-6108(02)00032-612086872
|
|
34.
|
S StreitCW MichalskiM ErkanH FriessJ
KleeffConfirmation of DNA microarray-derived differentially
expressed genes in pancreatic cancer using quantitative
RT-PCRPancreatology9577582200910.1159/00021208419657213
|
|
35.
|
A DokrasLM GardnerDA KirschmannEA SeftorMJ
HendrixThe tumour suppressor gene maspin is differentially
regulated in cytotrophoblasts during human placental
developmentPlacenta23274280200210.1053/plac.2001.078411969337
|
|
36.
|
M ZhangO VolpertYH ShiN BouckMaspin is an
angiogenesis inhibitorNat Med6196199200010.1038/72303
|
|
37.
|
HY ShiW ZhangR LiangModeling human breast
cancer metastasis in mice: maspin as a paradigmHistol
Histopathol18201206200312507299
|
|
38.
|
KM JoensuuMH LeideniusLC AnderssonPS
HeikkilaHigh expression of maspin is associated with early tumor
relapse in breast cancerHum
Pathol4011431151200910.1016/j.humpath.2009.02.00619427667
|
|
39.
|
HJ SonTS SohnSY SongJH LeeJC RheeMaspin
expression in human gastric adenocarcinomaPathol
Int52508513200210.1046/j.1440-1827.2002.01381.x12366809
|
|
40.
|
M TerashimaC MaesawaK OyamaGene expression
profiles in human gastric cancer: expression of maspin correlates
with lymph node metastasisBr J
Cancer9211301136200510.1038/sj.bjc.660242915770218
|
|
41.
|
M PaliourasC BorgonoEP DiamandisHuman
tissue kallikreins: the cancer biomarker familyCancer
Lett2496179200710.1016/j.canlet.2006.12.01817275179
|
|
42.
|
GM YousefCA BorgonoC PopalisIn-silico
analysis of kallikrein gene expression in pancreatic and colon
cancersAnticancer Res244351200415015574
|
|
43.
|
GM YousefNM WhiteIP MichaelIdentification
of new splice variants and differential expression of the human
kallikrein 10 gene, a candidate cancer biomarkerTumour
Biol26227235200510.1159/00008737716103744
|
|
44.
|
CD PetrakiAK GregorakisMM
VaslamatzisPrognostic implications of the immunohistochemical
expression of human kallikreins 5, 6, 10 and 11 in renal cell
carcinomaTumour Biol2717200610.1159/00009015016340244
|
|
45.
|
X BiH HeY YeAssociation of TMPRSS2 and
KLK11 gene expression levels with clinical progression of human
prostate cancerMed
Oncol27145151201010.1007/s12032-009-9185-019242826
|
